(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
3 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 4.91%
@ $32.28
发出时间: 15 Feb 2024 @ 03:36
回报率: -35.27%
上一信号: Feb 15 - 03:04
上一信号:
回报率: 1.14 %
Live Chart Being Loaded With Signals
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally...
Stats | |
---|---|
今日成交量 | 958 940 |
平均成交量 | 783 080 |
市值 | 1.01B |
EPS | $0 ( 2024-05-01 ) |
下一个收益日期 | ( $-0.210 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -31.65 |
ATR14 | $0.0250 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Noznesky Justin J | Sell | 1 500 | Common Stock |
2024-04-01 | Noznesky Justin J | Sell | 1 500 | Common Stock |
2024-03-18 | Dahlquist Karl S. | Sell | 1 885 | Common Stock |
2024-03-14 | Carrel Michael H | Sell | 2 000 | Common Stock |
2024-03-12 | Noznesky Justin J | Sell | 1 500 | Common Stock |
INSIDER POWER |
---|
47.39 |
Last 99 transactions |
Buy: 780 810 | Sell: 272 692 |
音量 相关性
AtriCure Inc 相关性 - 货币/商品
AtriCure Inc 财务报表
Annual | 2023 |
营收: | $399.25M |
毛利润: | $297.42M (74.49 %) |
EPS: | $-0.660 |
FY | 2023 |
营收: | $399.25M |
毛利润: | $297.42M (74.49 %) |
EPS: | $-0.660 |
FY | 2022 |
营收: | $330.38M |
毛利润: | $245.94M (74.44 %) |
EPS: | $-1.020 |
FY | 2021 |
营收: | $274.33M |
毛利润: | $205.86M (75.04 %) |
EPS: | $1.190 |
Financial Reports:
No articles found.
AtriCure Inc
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。